Personal history of diabetes, genetic susceptibility to diabetes, and risk of brain glioma: A pooled analysis of observational studies

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 1, 2014, Pages 47-54

  Kitahara, Cari M ^a   Linet, Martha S ^a   Brenner, Alina V ^a   Wang, Sophia S ^c   Melin, Beatrice S ^j   Wang, Zhaoming ^a,b   Inskip, Peter D ^a   Freeman, Laura E Beane ^a   Braganza, Melissa Z ^a   Carreón, Tania ^d   Feychting, Maria ^k   Gaziano, J Michael ^e,f,g   Peters, Ulrike ^h   Purdue, Mark P ^a   Ruder, Avima M ^d   Sesso, Howard D ^e,f   Shu, Xiao Ou ⁱ   Waters, Martha A ^d   White, Emily ^h   Zheng, Wei ⁱ   Hoover, Robert N ^a   Fraumeni Jr , Joseph F ^a   Chatterjee, Nilanjan ^a   Yeager, Meredith ^a,b   Chanock, Stephen J ^a,b   Hartge, Patricia ^a   Rajaraman, Preetha ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g VA BOSTON HEALTHCARE SYSTEM   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^j UMEÅ UNIVERSITY   (Sweden)

^k KAROLINSKA INSTITUTE   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GLIOBLASTOMA; GLIOMA; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RARE DISEASE; RISK; RISK FACTOR; SEX; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

AGED; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CHINA; DIABETES MELLITUS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLIOMA; HUMANS; MALE; MIDDLE AGED; OBSERVATIONAL STUDY AS TOPIC; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84892719560     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0913     Document Type: Article

References (37)

1. CBTRUS. Statistical Report: Primary brain and central nervous system tumors diagnosed in the United States in 2004-2008. Hinsdale, IL: Central Brain Tumor Registry of the United States; 2012.
2. Braganza MZ, Kitahara CM, Berrington de González A, Inskip PD, Johnson KJ, Rajaraman P. Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review. Neuro Oncol 2012;14:1316-24.
3. Cicuttini FM, Hurley SF, Forbes A, Donnan GA, Salzberg M, Giles GG, et al. Association of adult glioma with medical conditions, family and reproductive history. Int J Cancer 1997;71:203-7.
4. Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A, et al. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 1999;82:155-60.
5. Schlehofer B, Blettner M, Becker N, Martinsohn C, Wahrendorf J. Medical risk factors and the development of brain tumors. Cancer 1992;69:2541-7.
6. Brenner AV, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 2002;99:252-9.
7. Schwartzbaum J, Jonsson F, Ahlbom A, Preston-Martin S, Malmer B, Lönn S, et al. Prior hospitalization for epilepsy, diabetes, and stroke and subsequent glioma and meningioma risk. Cancer Epidemiol Biomarkers Prev 2005;14:643-50.
8. Stocks T, Rapp K, Bjørge T, Manjer J, Ulmer H, Selmer R, et al. Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med 2009;6:e1000201.
9. Swerdlow AJ, Laing SP, Qiao Z, Slater SD, Burden AC, Botha JL, et al. Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 2005;92:2070-5.
10. Mills PK, Preston-Martin S, Annegers JF, Beeson L, Phillips RL, Fraser GE. Risk factors for tumors of the brain and cranial meninges in Seventh-Day Adventists. Neuroepidemiology 1989;8:266-75.
11. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997;89: 1360-5.
12. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005;293:194-202.
13. Campbell PT, Newton CC, Patel AV, Jacobs EJ, Gapstur SM. Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults. Diabetes Care 2012;35:1835-44.
14. Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, et al. Diabetes and cancer: a consensus report. Diabetes Care 2010;33:1674-85.
15. Nokoff NJ, Rewers M, Cree Green M. The interplay of autoimmunity and insulin resistance in type 1 diabetes. Discov Med 2012;13: 115-22.
16. Chen C, Xu T, Chen J, Zhou J, Yan Y, Lu Y, et al. Allergy and risk of glioma: a meta-analysis. Eur J Neurol 2011;18:387-95.
17. Rajaraman P, Melin BS, Wang Z, McKean-Cowdin R, Michaud DS, Wang SS, et al. Genome-wide association study of glioma and metaanalysis. Hum Genet 2012;131:1877-88.
18. Alavanja MC, Sandler DP, McMaster SB, Zahm SH, McDonnell CJ, Lynch CF, et al. The Agricultural Health Study. Environ Health Perspect 1996;104:362-9.
19. Hatch EE, Linet MS, Zhang J, Fine HA, Shapiro WR, Selker RG, et al. Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer 2005;114:797-805.
20. Ruder AM, Waters MA, Carreon T, Butler MA, Davis-King KE, Calvert GM, et al. The Upper Midwest Health Study: a case-control study of primary intracranial gliomas in farm and rural residents. J Agric Saf Health 2006;12:255-74.
21. Steering Committee of the Physicians' Health Study Research Group. Final report of the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321:129-135.
22. Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, Schvartz M, et al. Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2012;308:1751-60.
23. Hayes RB, Reding D, Kopp W, Subar AF, Bhat N, Rothman N, et al. Etiologic and early marker studies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21: 349S-55S.
24. Zheng W, Chow WH, Yang G, Jin F, Rothman N, Blair A, et al. The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol 2005;162:1123-31.
25. Cai H, Zheng W, Xiang YB, Xu WH, Yang G, Li H, et al. Dietary patterns and their correlates among middle-aged and elderly Chinese men: a report from the Shanghai Men's Health Study. Br J Nutr 2007;98: 1006-13.
26. White E, Patterson RE, Kristal AR, Thornquist M, King I, Shattuck AL, et al. VITamins and Lifestyle cohort study: study design and characteristics of supplement users. Am J Epidemiol 2004;159:83-93.
27. Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007;39:906-13.
28. Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007;445:881-5.
29. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007;316: 1341-5.
30. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007;316:1331-6.
31. Yasuda K, Miyake K, Horikawa Y, Hara K, Osawa H, Furuta H, et al. Varients inKCNQ1are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 2008;40:1092-7.
32. Rung J, Cauchi S, Albrechtsen A, Shen L, Rocheleau G, Cavalcanti-Proenca C, et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet 2009; 41:1110-5.
33. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 2009;41:899-904.
34. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA, et al. Variants in the CDKN2B and RTEL1 regions are associated with highgrade glioma susceptibility. Nat Genet 2009;41:905-8.
35. Sanson M, Hosking FJ, Shete S, Zelenika D, Dobbins SE, Ma Y, et al. Chromosome 7p11.2 (EGFR) variation influences glioma risk. HumMol Genet 2011;20:2897-904.
36. AronsonSM, Aronson BE. Central nervous systemin diabetes mellitus: lowered frequency of certain intracranial neoplasms. Arch Neurol 1965;12:390-8.
37. Turner MC, Krewski D, Armstrong BK, Chetrit A, Giles GG, Hours M, et al. Allergy and brain tumors in the INTERPHONE study: pooled results from Australia, Canada, France, Israel, and New Zealand. Cancer Causes Control 2013;24:949-60.